Iberia Fundraising Pipeline - Q4 2020

Dec 2019

Magnum Capital III acquires majority stakes in Iberian companies operating primarily in the industrial and services sectors. The fund held two interim closings this year and expects to reach a final close in the first quarter of 2021, the GP told Unquote.

MCH Iberian Capital V invests in medium-sized companies headquartered in the Iberian peninsula, generating EBITDA of €5-15m. The fund held a €200m first close in April 2020 and expects to reach its final close in the coming months, the GP told Unquote.

Abac Sustainable Value II acquires majority stakes in Spanish medium-sized companies operating in the consumer, energy, industrials, technology, media and telecommunications sectors. The GP told Unquote that it plans to hold a first close in the coming weeks.

Portobello Structured Partnership I has a €300m hard-cap and acquires minority stakes in mid-market companies based primarily across Spain, but also in the rest of Europe. Target companies generate EBITDA in the €10-50m range. The GP told Unquote it expects to hold a close in the coming months.

GED VI España held a €100m first close in March 2019. It deploys equity tickets of €15-20m to acquire primarily majority but also minority stakes via buyouts and growth capital deals. The GP told Unquote that the fund is expected to reach a final close next year.

Mid-market
growth deals

Talde Capital Crecimiento II  has raised around €55m so far. The GP plans to hold a first close between December 2020 and January 2021, and a final close in around one year, it told Unquote.

Mid-market
growth deals

Suma Capital Growth II held a €65m first close in December 2019. The vehicle targets businesses with high-growth potential that are ESG-focused, operating in the niche manufacturing, specialised retail, business process outsourcing and e-commerce sectors. The fund is expected to hold a final close in Q1 2021, the GP told Unquote. 

Ysios BioFund III held a €155m first close in June 2020. The fund provides financing to early- and mid-stage life sciences companies that develop disruptive therapeutic products and technologies.

Nauta Tech Invest V held a €120m first close in July 2020. The fund deploys tickets of €1-5m in seed and series-A rounds, with the ability to follow-on with additional capital of up to €7m over the life of an investment.

Seaya Ventures III held an €85m first close in October 2020. The fund invests in technology companies based across southern Europe, with the aim of supporting their growth and boosting their international expansion.

Kibo Ventures

Kibo Ventures III held a first close in October 2020. It leads or co-leads pre-series-A and series-A rounds in European technology companies, primarily based in Spain and Portugal.

K Fund II was launched in June 2020 with a €70m target. The vehicle invests in early-stage Iberian startups.

Faber Tech II held a first close on €20.5m in November 2020. The fund invests in early-stage rounds, targeting data-driven startups based across southern Europe – primarily Iberia – with the aim of supporting their international expansion.

Oquendo Capital launched Oquendo IV in partnership with Banca March in June 2020. The fund invests in Spanish mid-market companies, deploying tickets of €5-25m.

Gaea Inversion held a €55m first close in January 2020. The fund deploys equity as well as hybrid instruments and debt facilities of €2-20m.

Talde Deuda Alternativa has raised €65m so far. The fund invests tickets of €5-15m in mid-market companies.